Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CodeBreak 101 sotorasib master protocol in KRAS G12C advanced colorectal or pancreatic cancer
NL-OMON53961Phase 1Recruiting
- Sponsor
- Amgen
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sotorasib in colorectal cancer (CRC) and pancreatic cancer (PC), sponsored by Amgen. Started Feb 2023; status: recruiting.
02
Drugs
sotorasib
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NL-OMON53961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53961.